60. Mainardes RM, Evangelista RC (2005) Praziquantel-loaded PLGA nanoparticles: preparation and characterization. J Microencapsul 22:13–24
61. Quintanar-Guerrero D, Allemann E, Fessi H et al (1998) Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind
Pharm 24:1113–1128
62. Bindschaedler C, Gurny R, Doelker E (1990) Process for preparing a powder of waterinsoluble polymer which can be redispersed in a liquid phase, the resulting powder and
utilization thereof. US Patent 4,968,350
63. Allemann E, Gurny R, Doelker E (1992) Preparation of aqueous polymeric nanodispersions
by a reversible salting-out process: influence of process parameters on particle size. Int J
Pharm 87:247–253
64. Zhang Z, Grijpma DW, Feijen J (2006) Poly (trimethylene carbonate) and monomethoxy
poly (ethylene glycol)-block-poly(trimethylene carbonate) nanoparticles for the controlled
release of dexamethasone. J Control Release 111:263–270
65. Fessi H, Puisieux F, Devissaguet JP et al (1989) Nanocapsule formation by interfacial
polymer deposition following solvent displacement. Int J Pharm 55:1–4
66. Mishra B, Patel BB, Tiwari S (2010) Colloidal nanocarriers: a review on formulation
technology, types and applications toward targeted drug delivery. Nanomedicine 6:9–24
67. Thioune O, Fessi H, Devissaguet JP et al (1997) Preparation of pseudolatex by nanoprecipitation: influence of the solvent nature on intrinsic viscosity and interaction constant. Int J
Pharm 146:233–238
68. Moinard-Checot D, Chevalier Y, Briancon S et al (2008) Mechanism of nanocapsules
formation by the emulsion–diffusion process. J Colloid Interface Sci 317:458–468
69. Kim E, Yang J, Choi J et al (2009) Synthesis of gold nanorod-embedded polymeric
nanoparticles by a nanoprecipitation method for use as photothermal agents. Nanotechnology
20:365602
70. Legrand P, Lesieur S, Bochot A et al (2007) Influence of polymer behaviour in organic
solution on the production of polylactide nanoparticles by nanoprecipitation. Int J Pharm
344:33–43
71. Nehilla BJ, Bergkvist M, Popat KC et al (2008) Purified and surfactant free coenzyme Q10loaded biodegradable nanoparticles. Int J Pharm 348:107–114
72. Yallapu MM, Gupta BK, Jaggi M et al (2010) Fabrication of curcumin encapsulated PLGA
nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface
Sci 351:19–29
73. Jeong YI, Cho CS, Kim SH et al (2001) Preparation of poly (D-L-lactide-co-glycolide)
nanoparticles without surfactant. J Appl Polym Sci 80:2228–2236
74. Kostog M, Kohler S, Liebert T et al (2010) Pure cellulose nanoparticles from trimethylsilyl
cellulose. Macromol Symp 294:96–106
75. Barichello JM, Morishita M, Takayama K et al (1999) Encapsulation of hydrophilic and
lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind
Pharm 25:471–476
76. Nemati F, Dubernet C, Fessi H et al (1996) Reversion of multidrug resistance using
nanoparticles in vitro: influence of the nature of the polymer. Int J Pharm 138:237–246
77. Mu L, Feng SS (2003) A novel controlled release formulation for the anticancer drug
paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release
86:33–48
78. Prabha S, Zhou W-Z, Panyam J et al (2002) Size-dependency of nanoparticle-mediated gene
transfection studies with fractionated nanoparticles. Int J Pharm 244:105–115
79. Sanchez A, Vila Jato JL, Alonso MJ (1993) Development of biodegradable microspheres and
nanospheres for the controlled release of cyclosporine. Int J Pharm 99:263–273
80. Gomez-Gaete C, Tsapis N, Besnard M et al (2007) Encapsulation of dexamethasone into
biodegradable polymeric nanoparticles. Int J Pharm 331:153–159
Biodegradable Polymers for Potential Delivery Systems for Therapeutics
197
61. Quintanar-Guerrero D, Allemann E, Fessi H et al (1998) Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind
Pharm 24:1113–1128
62. Bindschaedler C, Gurny R, Doelker E (1990) Process for preparing a powder of waterinsoluble polymer which can be redispersed in a liquid phase, the resulting powder and
utilization thereof. US Patent 4,968,350
63. Allemann E, Gurny R, Doelker E (1992) Preparation of aqueous polymeric nanodispersions
by a reversible salting-out process: influence of process parameters on particle size. Int J
Pharm 87:247–253
64. Zhang Z, Grijpma DW, Feijen J (2006) Poly (trimethylene carbonate) and monomethoxy
poly (ethylene glycol)-block-poly(trimethylene carbonate) nanoparticles for the controlled
release of dexamethasone. J Control Release 111:263–270
65. Fessi H, Puisieux F, Devissaguet JP et al (1989) Nanocapsule formation by interfacial
polymer deposition following solvent displacement. Int J Pharm 55:1–4
66. Mishra B, Patel BB, Tiwari S (2010) Colloidal nanocarriers: a review on formulation
technology, types and applications toward targeted drug delivery. Nanomedicine 6:9–24
67. Thioune O, Fessi H, Devissaguet JP et al (1997) Preparation of pseudolatex by nanoprecipitation: influence of the solvent nature on intrinsic viscosity and interaction constant. Int J
Pharm 146:233–238
68. Moinard-Checot D, Chevalier Y, Briancon S et al (2008) Mechanism of nanocapsules
formation by the emulsion–diffusion process. J Colloid Interface Sci 317:458–468
69. Kim E, Yang J, Choi J et al (2009) Synthesis of gold nanorod-embedded polymeric
nanoparticles by a nanoprecipitation method for use as photothermal agents. Nanotechnology
20:365602
70. Legrand P, Lesieur S, Bochot A et al (2007) Influence of polymer behaviour in organic
solution on the production of polylactide nanoparticles by nanoprecipitation. Int J Pharm
344:33–43
71. Nehilla BJ, Bergkvist M, Popat KC et al (2008) Purified and surfactant free coenzyme Q10loaded biodegradable nanoparticles. Int J Pharm 348:107–114
72. Yallapu MM, Gupta BK, Jaggi M et al (2010) Fabrication of curcumin encapsulated PLGA
nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface
Sci 351:19–29
73. Jeong YI, Cho CS, Kim SH et al (2001) Preparation of poly (D-L-lactide-co-glycolide)
nanoparticles without surfactant. J Appl Polym Sci 80:2228–2236
74. Kostog M, Kohler S, Liebert T et al (2010) Pure cellulose nanoparticles from trimethylsilyl
cellulose. Macromol Symp 294:96–106
75. Barichello JM, Morishita M, Takayama K et al (1999) Encapsulation of hydrophilic and
lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind
Pharm 25:471–476
76. Nemati F, Dubernet C, Fessi H et al (1996) Reversion of multidrug resistance using
nanoparticles in vitro: influence of the nature of the polymer. Int J Pharm 138:237–246
77. Mu L, Feng SS (2003) A novel controlled release formulation for the anticancer drug
paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release
86:33–48
78. Prabha S, Zhou W-Z, Panyam J et al (2002) Size-dependency of nanoparticle-mediated gene
transfection studies with fractionated nanoparticles. Int J Pharm 244:105–115
79. Sanchez A, Vila Jato JL, Alonso MJ (1993) Development of biodegradable microspheres and
nanospheres for the controlled release of cyclosporine. Int J Pharm 99:263–273
80. Gomez-Gaete C, Tsapis N, Besnard M et al (2007) Encapsulation of dexamethasone into
biodegradable polymeric nanoparticles. Int J Pharm 331:153–159
Biodegradable Polymers for Potential Delivery Systems for Therapeutics
197